To the Editor: Costello and Murphy’s lament1 about the discoverer of prostate-specific antigen (PSA), Richard Ablin, describing PSA testing as a “hugely expensive public health disaster”2 contains several egregious claims that require correction. They write that “since the introduction of PSA testing in the 1980s, we have seen a 25% reduction in mortality” from the disease.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Costello AJ, Murphy DG. Has PSA testing truly been a “public health disaster” [editorial]? Med J Aust 2010; 193: 4-5. <MJA full text>
- 2. Ablin RJ. The great prostate mistake. New York Times 2010; 9 Mar. http://www.nytimes.com/2010/03/10/opinion/10Ablin.html (accessed Jul 2010).
- 3. Australian Institute of Health and Welfare. Cancer — Australian cancer statistics update, May 2010. http://www.aihw.gov.au/cancer/index.cfm (accessed Jul 2010).
- 4. Smith DP, King MT, Egger S, et al. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ 2009; 339: b4817.
- 5. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-1328.
- 6. Kolata G. Prostate test found to save few lives. New York Times 2009; 18 Mar. http://www.nytimes.com/2009/03/19/health/19cancer.html (accessed Jul 2010).
Online responses are no longer available. Please refer to our instructions for authors page for more information.
Simon Chapman has received payment as a Board Member of Cancer Australia. His comments here do not necessarily reflect those of Cancer Australia.